What is Amphastar Pharmaceuticals's debt-to-assets?

Amphastar Pharmaceuticals (AMPH) reported debt-to-assets of 0.4× in Q1 2026.

How has Amphastar Pharmaceuticals's debt-to-assets changed year-over-year?

Amphastar Pharmaceuticals's debt-to-assets increased by 3.8% year-over-year, from 0.4× to 0.4×.

What is the long-term trend for Amphastar Pharmaceuticals's debt-to-assets?

Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's debt-to-assets has grown at a 30.3% compound annual growth rate (CAGR), from 0.1× to 0.4×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Amphastar Pharmaceuticals AMPH Debt-to-assets

Debt-to-assets at other companies

PfizerPFE

0.3×0.0×

Halozyme TherapeuticsHALO

0.8×+0.1×

ViatrisVTRS

0.4×0.0×

Opko HealthOPK

0×0.0×

AptarGroupATR

0.3×0.0×

ARS Pharmaceuticals, Inc.SPRY

0.3×+0.3×

Other financials

Income statement

See full

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.4%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Calculated from Amphastar Pharmaceuticals’s reported figures.

total debt/total assets=0.4×

Based on the most recent quarter.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's debt-to-assets?: Amphastar Pharmaceuticals (AMPH) reported debt-to-assets of 0.4× in Q1 2026.
How has Amphastar Pharmaceuticals's debt-to-assets changed year-over-year?: Amphastar Pharmaceuticals's debt-to-assets increased by 3.8% year-over-year, from 0.4× to 0.4×.
What is the long-term trend for Amphastar Pharmaceuticals's debt-to-assets?: Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's debt-to-assets has grown at a 30.3% compound annual growth rate (CAGR), from 0.1× to 0.4×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.